scholarly article | Q13442814 |
P356 | DOI | 10.1080/13506129.2017.1292240 |
P698 | PubMed publication ID | 28434298 |
P50 | author | Giovanni Palladini | Q37839091 |
Giampaolo Merlini | Q37839101 | ||
Paolo Milani | Q44254925 | ||
Stefan Schönland | Q47114671 | ||
Stefano Perlini | Q57005375 | ||
Tilmann Bochtler | Q92866574 | ||
P2093 | author name string | Francesca Russo | |
Anthony D Ho | |||
Andrea Foli | |||
Ute Hegenbart | |||
Christoph Kimmich | |||
Marco Basset | |||
P2860 | cites work | Bendamustine: rebirth of an old drug | Q34947495 |
A practical approach to the diagnosis of systemic amyloidoses. | Q41505050 | ||
New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes | Q44572498 | ||
Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissue. | Q50526227 | ||
What is new in diagnosis and management of light chain amyloidosis? | Q50863530 | ||
Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients. | Q54337852 | ||
A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis | Q58029845 | ||
P433 | issue | sup1 | |
P921 | main subject | bendamustine | Q425745 |
AL amyloidosis | Q4652470 | ||
P304 | page(s) | 56-57 | |
P577 | publication date | 2017-03-01 | |
P1433 | published in | Amyloid | Q4749545 |
P1476 | title | Response to bendamustine is associated with a survival advantage in a heavily pretreated patients with AL amyloidosis | |
P478 | volume | 24 |